Evolent Health (FRA:9EH) Cyclically Adjusted Book per Share: €10.05 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:9EH Evolent Health Inc FRA:9EH
63 GF Score
Price €5.05
GF Value €9.69
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Evolent Health Cyclically Adjusted Book per Share?

Evolent Health FRA:9EH +3.06% 63 Cyclically Adjusted Book per Share is €10.05 as of Mar. 2026. GuruFocus rates FRA:9EH with a GF Score™ of 63/100 and a GF Value™ of €9.69 (Possible Value Trap). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Evolent Health's adjusted book value per share for the three months ended in Mar. 2026 was €3.048. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €10.05 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Evolent Health's average Cyclically Adjusted Book Growth Rate was -8.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-21), Evolent Health's current stock price is €5.05. Evolent Health's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €10.05. Evolent Health's Cyclically Adjusted PB Ratio of today is 0.50.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Evolent Health was 2.67. The lowest was 0.18. And the median was 0.77.


Evolent Health  (FRA:9EH) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Evolent Health's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=5.05/10.05
=0.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Evolent Health was 2.67. The lowest was 0.18. And the median was 0.77.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Evolent Health Cyclically Adjusted Book per Share Related Terms


Evolent Health Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Evolent Health's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evolent Health Cyclically Adjusted Book per Share Chart

Evolent Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 11.77 12.39 10.47

Evolent Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.20 10.89 11.13 10.47 10.05

FRA:9EH vs PHR, CTEV, MDRX: Cyclically Adjusted Book per Share Comparison

For the Health Information Services subindustry, Evolent Health's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evolent Health Cyclically Adjusted PB Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Evolent Health's Cyclically Adjusted PB Ratio falls into.


FRA:9EH
63GF Score
Evolent Health Inc FRA:9EH
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evolent Health Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Evolent Health's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=3.048/330.2130*330.2130
=3.048

Current CPI (Mar. 2026) = 330.2130.

Evolent Health Quarterly Data

Book Value per Share CPI Adj_Book
201606 11.216 241.018 15.367
201609 11.125 241.428 15.216
201612 12.665 241.432 17.322
201703 12.305 243.801 16.666
201706 11.635 244.955 15.685
201709 11.461 246.819 15.333
201712 11.431 246.524 15.312
201803 10.990 249.554 14.542
201806 11.489 251.989 15.055
201809 11.354 252.439 14.852
201812 12.699 251.233 16.691
201903 12.257 254.202 15.922
201906 11.939 256.143 15.391
201909 12.007 256.759 15.442
201912 9.814 256.974 12.611
202003 8.971 258.115 11.477
202006 6.722 257.797 8.610
202009 6.349 260.280 8.055
202012 6.038 260.474 7.655
202103 6.083 264.877 7.583
202106 5.951 271.696 7.233
202109 6.010 274.310 7.235
202112 6.880 278.802 8.149
202203 6.163 287.504 7.079
202206 6.436 296.311 7.172
202209 8.680 296.808 9.657
202212 8.116 296.797 9.030
202303 9.438 301.836 10.325
202306 8.923 305.109 9.657
202309 9.069 307.789 9.730
202312 8.597 306.746 9.255
202403 8.408 312.332 8.889
202406 8.534 314.175 8.970
202409 8.137 315.301 8.522
202412 8.312 315.605 8.697
202503 7.469 319.799 7.712
202506 6.701 322.561 6.860
202509 6.430 324.800 6.537
202512 3.176 324.054 3.236
202603 3.048 330.213 3.048

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €10.05 mean?
Evolent Health (FRA:9EH) has a Cyclically Adjusted Book per Share of €10.05 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Evolent Health and its competitors.
Is Evolent Health's Cyclically Adjusted Book per Share too high?
Evolent Health's current Cyclically Adjusted Book per Share is €10.05. Overall, Evolent Health has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evolent Health's Cyclically Adjusted Book per Share compare to PHR and CTEV?
Evolent Health's Cyclically Adjusted Book per Share of €10.05 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Book per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Evolent Health and its competitors. Evolent Health's current Cyclically Adjusted Book per Share is €10.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolent Health stock overvalued right now?
Based on GuruFocus' analysis, Evolent Health (FRA:9EH) is currently considered Possible Value Trap. The stock's GF Value™ is €9.69, compared to a current price of €5.05 — trading 47.9% below its estimated fair value. The current Cyclically Adjusted Book per Share is €10.05. Evolent Health's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Evolent Health (FRA:9EH), the current Cyclically Adjusted Book per Share is €10.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Evolent Health (FRA:9EH) Overvalued in 2026?

Based on GuruFocus' analysis, Evolent Health stock appears to be undervalued. The current stock price of €5.05 is trading 47.9% below its estimated GF Value™ of €9.69. GuruFocus considers Evolent Health to be Possible Value Trap.

Key valuation signals for FRA:9EH:

  • Cyclically Adjusted Book per Share: €10.05
  • GF Value™: €9.69 vs. price of €5.05 (47.9% below fair value)
  • GF Score™: 63/100 with 7 warning signs

No single metric tells the full story. See the FRA:9EH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Evolent Health Business Description

Other Exchanges EVH:USA9EH:Germany
Address 1812 North Moore Street, Suite 1705, Arlington, VA, USA, 22209
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
63GF Score

Get the complete analysis for FRA:9EH

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.05
Price
€9.69
GF Value